Summary

for people ages 18-60 (full criteria)
study started
estimated completion:
Dawn Eichen

Description

Summary

Currently, the best behavioral treatments for obesity only work for 50% of adults, and of those who initially succeed, most do not maintain their weight loss. One reason for this failure may be due to neurocognitive deficits found among individuals with obesity, particularly related to executive function, which make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop a Novel Executive Function Treatment (NEXT), which when administered prior to the behavioral treatment, could help improve outcomes by addressing the neurocognitive deficits in adults with overweight or obesity.

Details

First, to assist with treatment development, two groups of approximately 10 participants will be enrolled in a 12-week open-label treatment group of NEXT. These participants will then provide qualitative feedback to help with treatment development. After the two pilot groups, a randomized control trial will evaluate NEXT compared to standard BWL to assess feasibility, acceptability and preliminary efficacy.

Keywords

Overweight and Obesity weight loss executive function Obesity Overweight Behavioral Weight Loss - BWL Novel Executive Function Training - NEXT

Eligibility

You can join if…

Open to people ages 18-60

  • Age 18-60
  • Ability to read English at a 6th grade level
  • BMI >25 and ≤45
  • Lower than average executive functioning based on the BRIEF-A

You CAN'T join if...

  • Medical condition that requires physician monitoring to participate in weight control program or prohibits safely participating in recommended physical activity
  • Psychiatric condition that could interfere with program participant (e.g., substance abuse, suicide attempt within previous 6 months, active purging)
  • Currently pregnant, lactating or plan to be in the timespan of program follow-up
  • Current enrollment in an organized weight control program
  • Change in psychotropic medication or other medication that could have impact on weight during the previous 3 months
  • History of bariatric surgery
  • History of learning disorder, neurological condition or injury, or IQ<80

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT03724396
Lead Scientist
Dawn Eichen
Study Type
Interventional
Last Updated